Pharma B2B eCommerce Market by Business Model (B2B2B, B2B2C), Product Type (Over-the-Counter (OTC) Products, Prescription Drugs), Therapeutic Area, Distribution Type - Global Forecast 2024-2030

Pharma B2B eCommerce Market by Business Model (B2B2B, B2B2C), Product Type (Over-the-Counter (OTC) Products, Prescription Drugs), Therapeutic Area, Distribution Type - Global Forecast 2024-2030


The Pharma B2B eCommerce Market size was estimated at USD 28.11 billion in 2023 and expected to reach USD 30.23 billion in 2024, at a CAGR 7.70% to reach USD 47.27 billion by 2030.

Global Pharma B2B eCommerce MarketOnline pharma B2B marketplace connects pharmaceutical manufacturers, distributors, and retailers to procure drugs and provides real-time supply and demand information via the platform to maintain inventory. Pharma B2B eCommerce offers pharmaceutical buyers and sellers solutions to explore new market opportunities and optimize cost management. The emergence of digital transformation in pharmacies and healthcare providers in developing countries is increasing the utilization of pharma B2B eCommerce platforms to attract a new customer base. The improvements in the procurement process with purchase controls and maintenance of regulatory control and traceability in pharma products contribute to the adoption of pharma B2B eCommerce platforms in the market. However, the complex integration process of eCommerce platforms with the existing systems in pharmacies may limit the adoption of B2B eCommerce platforms in the market. Additionally, the issues related to pharmaceutical product quality are limiting market growth factors. Moreover, rapid growth in developing personalized approaches and increasing investment to improve the operational efficiencies of pharma B2B eCommerce platforms are expected to create lucrative growth opportunities in the market.

Regional Insights

The pharma B2B eCommerce market in the Americas is growing, owing to the highly established digital infrastructure, and market players are shifting towards B2B eCommerce of pharmaceutical drugs to improve customer service while attracting new clients. Pharma companies in the region have increasingly joined forces with other industry stakeholders, such as drug manufacturers, distributors, and technology providers, to achieve mutual benefits such as shared expertise and resources to expand product offerings worldwide. Growing investments from the private sector and supportive healthcare infrastructure have expanded the scope of pharmaceutical B2B eCommerce in European countries, including the United Kingdom and Germany. The market players in the region are focusing on innovative marketing strategies and straightening supply chains among strict regulatory guidelines to reach unexplored pharma markets in developing African countries with an easy-to-use online ordering portal. In addition, the Asia-Pacific market is evolving due to the emergence of mobile-based platforms that provide pharmacists and pharmaceutical companies with a marketplace platform to procure drugs, provide real-time info about supply and demand via the platform, and enable pharmacists to understand more about the different medicines. The growing digitalization in Asian countries such as China, Japan, and India contributes to the rising optimization of the pharmaceutical supply chain, which helps to attract new customers through online marketplaces for pharmaceutical manufacturers.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Pharma B2B eCommerce Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Pharma B2B eCommerce Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Pharma B2B eCommerce Market, highlighting leading vendors and their innovative profiles. These include Amazon.com, Inc., AmerisourceBergen Corporation, Ayro Retail Solutions Pvt. Ltd, Becton, Dickinson & Company, Biddano Pvt Ltd., Cardinal Health, Inc., Cloudfy Ltd., Corevist, Inc., Divante S.A., Entersoft SA, Eurofins Scientific, EuroPlux, GXgate, Henry Schein, Inc., hystrix medical AG, Invertus, Mckesson Corporation, Medcombo by Behmpat Producciones S.L, Medideals Resources LLP, Merck KGaA, Ochre Media Pvt Ltd, Oro, Inc., Pharma Vends by Hivends Info Solutions Pvt. Ltd, Pharmaflair, Pharmaoffer, PHARMATRADZ, Piegon Media Pvt. Ltd., PipelinePharma, Remedial Health Solutions Limited, Sandoz by Novartis AG, Thermo Fisher Scientific, Inc., TrueCommerce Inc., Trxade, Health Inc., Wizarma Healthcare Private Limited, and Yaoshibang.

Market Segmentation & Coverage

This research report categorizes the Pharma B2B eCommerce Market to forecast the revenues and analyze trends in each of the following sub-markets:

Business Model
B2B2B
B2B2C
Product Type
Over-the-Counter (OTC) Products
Prescription Drugs
Diabetes Management
Specialty Care
Vaccines
Therapeutic Area
Cardiovascular
Dermatology
Gastroenterology
Infectious Diseases
Neurology
Oncology
Respiratory
Distribution Type
Distributor/Wholesaler-Owned Digital eCommerce
Pharmaceutical Manufacturer-Owned Digital eCommerce
Region
Americas
Argentina
Brazil
Canada
Mexico
United States
California
Florida
Illinois
New York
Ohio
Pennsylvania
Texas
Asia-Pacific
Australia
China
India
Indonesia
Japan
Malaysia
Philippines
Singapore
South Korea
Taiwan
Thailand
Vietnam
Europe, Middle East & Africa
Denmark
Egypt
Finland
France
Germany
Israel
Italy
Netherlands
Nigeria
Norway
Poland
Qatar
Russia
Saudi Arabia
South Africa
Spain
Sweden
Switzerland
Turkey
United Arab Emirates
United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Pharma B2B eCommerce Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Pharma B2B eCommerce Market?
3. What are the technology trends and regulatory frameworks in the Pharma B2B eCommerce Market?
4. What is the market share of the leading vendors in the Pharma B2B eCommerce Market?
5. Which modes and strategic moves are suitable for entering the Pharma B2B eCommerce Market?

Note: PDF & Excel + Online Access - 1 Year


1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Pharma B2B eCommerce Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Embracing digital transformation in pharmacies and healthcare providers
5.1.1.2. Improve the procurement process with purchase controls and reduce the complexity of carriage handling
5.1.1.3. Need to maintain regulatory control and traceability in pharma with restricted catalogs
5.1.2. Restraints
5.1.2.1. Complex integration of eCommerce platforms with the existing systems
5.1.3. Opportunities
5.1.3.1. Rapid growth in developing personalized approaches and improving the customer experiences
5.1.3.2. Increasing investment to improve the operational efficiencies of pharma B2B eCommerce platforms
5.1.4. Challenges
5.1.4.1. Issues associated with the counterfeit and quality concerns of the pharma products
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
6. Pharma B2B eCommerce Market, by Business Model
6.1. Introduction
6.2. B2B2B
6.3. B2B2C
7. Pharma B2B eCommerce Market, by Product Type
7.1. Introduction
7.2. Over-the-Counter (OTC) Products
7.3. Prescription Drugs
7.4.1. Diabetes Management
7.4.2. Specialty Care
7.4.3. Vaccines
8. Pharma B2B eCommerce Market, by Therapeutic Area
8.1. Introduction
8.2. Cardiovascular
8.3. Dermatology
8.4. Gastroenterology
8.5. Infectious Diseases
8.6. Neurology
8.7. Oncology
8.8. Respiratory
9. Pharma B2B eCommerce Market, by Distribution Type
9.1. Introduction
9.2. Distributor/Wholesaler-Owned Digital eCommerce
9.3. Pharmaceutical Manufacturer-Owned Digital eCommerce
10. Americas Pharma B2B eCommerce Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific Pharma B2B eCommerce Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam
12. Europe, Middle East & Africa Pharma B2B eCommerce Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom
13. Competitive Landscape
13.1. FPNV Positioning Matrix
13.2. Market Share Analysis, By Key Player
13.3. Competitive Scenario Analysis, By Key Player
13.3.1. New Product Launch & Enhancement
13.3.1.1. Asian Healthcare Group Develops Vital High-Tech Platform, Beating Back COVID-19
13.3.2. Investment & Funding
13.3.2.1. Saveo Raises USD 4.5 Mn To Streamline B2B Pharma Supply Chain
13.3.3. Award, Recognition, & Expansion
13.3.3.1. Udaan Announces ‘4x4 Delivery Service’ For Pharmacies
14. Competitive Portfolio
14.1. Key Company Profiles
14.1.1. Amazon.com, Inc.
14.1.2. AmerisourceBergen Corporation
14.1.3. Ayro Retail Solutions Pvt. Ltd
14.1.4. Becton, Dickinson & Company
14.1.5. Biddano Pvt Ltd.
14.1.6. Cardinal Health, Inc.
14.1.7. Cloudfy Ltd.
14.1.8. Corevist, Inc.
14.1.9. Divante S.A.
14.1.10. Entersoft SA
14.1.11. Eurofins Scientific
14.1.12. EuroPlux
14.1.13. GXgate
14.1.14. Henry Schein, Inc.
14.1.15. hystrix medical AG
14.1.16. Invertus
14.1.17. Mckesson Corporation
14.1.18. Medcombo by Behmpat Producciones S.L
14.1.19. Medideals Resources LLP
14.1.20. Merck KGaA
14.1.21. Ochre Media Pvt Ltd
14.1.22. Oro, Inc.
14.1.23. Pharma Vends by Hivends Info Solutions Pvt. Ltd
14.1.24. Pharmaflair
14.1.25. Pharmaoffer
14.1.26. PHARMATRADZ
14.1.27. Piegon Media Pvt. Ltd.
14.1.28. PipelinePharma
14.1.29. Remedial Health Solutions Limited
14.1.30. Sandoz by Novartis AG
14.1.31. Thermo Fisher Scientific, Inc.
14.1.32. TrueCommerce Inc.
14.1.33. Trxade, Health Inc.
14.1.34. Wizarma Healthcare Private Limited
14.1.35. Yaoshibang
14.2. Key Product Portfolio
15. Appendix
15.1. Discussion Guide
15.2. License & Pricing
FIGURE 1. PHARMA B2B ECOMMERCE MARKET RESEARCH PROCESS
FIGURE 2. PHARMA B2B ECOMMERCE MARKET SIZE, 2023 VS 2030
FIGURE 3. PHARMA B2B ECOMMERCE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. PHARMA B2B ECOMMERCE MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. PHARMA B2B ECOMMERCE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. PHARMA B2B ECOMMERCE MARKET DYNAMICS
FIGURE 7. PHARMA B2B ECOMMERCE MARKET SIZE, BY BUSINESS MODEL, 2023 VS 2030 (%)
FIGURE 8. PHARMA B2B ECOMMERCE MARKET SIZE, BY BUSINESS MODEL, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. PHARMA B2B ECOMMERCE MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2030 (%)
FIGURE 10. PHARMA B2B ECOMMERCE MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. PHARMA B2B ECOMMERCE MARKET SIZE, BY THERAPEUTIC AREA, 2023 VS 2030 (%)
FIGURE 12. PHARMA B2B ECOMMERCE MARKET SIZE, BY THERAPEUTIC AREA, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. PHARMA B2B ECOMMERCE MARKET SIZE, BY DISTRIBUTION TYPE, 2023 VS 2030 (%)
FIGURE 14. PHARMA B2B ECOMMERCE MARKET SIZE, BY DISTRIBUTION TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS PHARMA B2B ECOMMERCE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 16. AMERICAS PHARMA B2B ECOMMERCE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES PHARMA B2B ECOMMERCE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 18. UNITED STATES PHARMA B2B ECOMMERCE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC PHARMA B2B ECOMMERCE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC PHARMA B2B ECOMMERCE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA PHARMA B2B ECOMMERCE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA PHARMA B2B ECOMMERCE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 23. PHARMA B2B ECOMMERCE MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 24. PHARMA B2B ECOMMERCE MARKET SHARE, BY KEY PLAYER, 2023

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings